Steth IO
Steth IO builds a smartphone-connected digital stethoscope (Spot) and a telemedicine platform that lets healthcare providers capture, visualize, and diagnose heart and lung sounds during remote audio-visual visits, serving US providers, practices, health systems, and chronic-care patients.
- Company typePrivate
- Founded2015
- HeadquartersBothell, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Steth IO does
Steth IO (legal entity StratoScientific, Inc.) is a Bothell, Washington-based medical device and software company that develops a smartphone-compatible digital stethoscope (Spot) and a telemedicine platform enabling remote cardiopulmonary examination. The Spot device connects to a patient's smartphone to capture heart and lung sounds, which are then transmitted over a cloud platform and displayed visually to providers during live audio-visual telemedicine visits — intended to give clinicians diagnostic information comparable to in-person auscultation. The platform also operates under the Telaspot sub-brand, which bundles scheduling, messaging, remote patient monitoring, and one-click virtual-clinic deployment into a customizable branded environment for healthcare providers.
The company's technology stack rests on an acoustic collection system protected by multiple granted US utility patents (with parallel design and utility filings in China, Japan, Canada, and the EU) covering the smartphone-coupled stethoscope form factor and a visual sound-representation interface. Steth IO monetizes through a mix of one-time hardware sales of the Spot device, recurring software subscriptions to its telemedicine platform (with customized pricing for providers and health systems), and in-app purchases for additional features. Distribution is multi-modal: direct enterprise sales to healthcare institutions, a self-serve PLG motion through Telaspot for small practices, and an embedded app within Cisco Webex (announced May 2024) that leverages Webex's enterprise collaboration install base.
The company was founded in 2015 by interventional cardiologist Dr. Mahesh Mulumudi and technology veteran Dr. Craig Rosenberg, with operational leadership including COO Avani Vimawala and VP of Strategy Jess Corrick. Steth IO has raised approximately $1.9M in disclosed funding across 2015, 2018, and 2020 (the last being a Newchip Accelerator participation), employs 1-10 people, and serves US-based healthcare providers, small practices, large health systems, payers, and chronic-condition patients as its primary customer segments. No institutional venture rounds have been disclosed since 2018, and no public revenue figures are available.
Steth IO firmographics
Firmographics- Name
- Steth IO
- Legal name
- StratoScientific, Inc.
- Website
- https://stethio.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Steth IO builds a smartphone-connected digital stethoscope (Spot) and a telemedicine platform that lets healthcare providers capture, visualize, and diagnose heart and lung sounds during remote audio-visual visits, serving US providers, practices, health systems, and chronic-care patients.
- Ownership category
- akta.pro rank
Steth IO industry classification
Industry- Product category
- Telemedicine and Remote Patient Monitoring
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Communications Equipment, Nec (3669)
- akta.pro primary industry
- Cardiology Telemedicine Platforms (HLALAGAB)
- akta.pro secondary industries
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Urgent Care + ePrescribing & Lab/Imaging Ordering Telehealth Platforms (HLALAJAL)
Keywords
Where Steth IO is headquartered
LocationHeadquarters
- HQ city
- Bothell
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Steth IO business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Hardware Device Sales (Spot): Sale of the Steth IO Spot digital stethoscope device that connects to smartphones for capturing heart and lung sounds. The device is shipped directly to patients' homes within four days of ordering.
- Software Platform Subscription: Telemedicine platform subscription for healthcare institutions to enroll clinical staff, patients, and access the central repository of securely collected clinical information during clinical care. EULA mentions in-app purchases for additional features.
- In-App Purchases: Additional features or functionality available for purchase through the application, including premium capabilities within the platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Customized platform pricing for providers and clinics |
| Unit Pricing | One time/ perpetual license | Connected device (Spot stethoscope) |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
Steth IO product offering
Product offeringCore offering
Steth IO develops and sells a smartphone-compatible digital stethoscope device (Spot) paired with a cloud-based telemedicine platform that enables healthcare providers to conduct remote cardiopulmonary examinations during live audio-visual visits. The platform visually represents heart and lung sounds captured by the connected device, allowing physicians to diagnose abnormalities with greater accuracy than traditional telemedicine. The Telaspot continuous care platform extends this with integrated scheduling, messaging, and remote patient monitoring capabilities for healthcare institutions.
Product overview
Steth IO offers a telemedicine platform architecture consisting of a core software platform (Steth IO Platform) combined with a hardware device (Steth IO Spot) that captures heart and lung sounds via smartphone. The platform integrates with the Telaspot sub-brand for scalable continuous care management including scheduling, messaging, and RPM. The Steth IO Spot is a smartphone-compatible digital stethoscope that plugs into patients' phones to capture auscultation data which is then transmitted and displayed visually to providers during live telemedicine visits. An embedded app version for Cisco Webex extends the platform's availability within enterprise collaboration environments. Together these components enable remote cardiopulmonary examination that rivals in-person clinical visits by combining live audio-visual communication with device-enabled diagnostic data capture and visualization.
Differentiator
Problem solved
Functional benefit
Brands
- Telaspot: A telehealth, remote patient monitoring, and communication platform by Steth IO that provides next-generation telemedicine with all-in-one capabilities including scheduling patient visits, audio-visual calls with device-enabled diagnostic capabilities, messaging between patients and physicians, and remote patient monitoring.
Products and services
- Steth IO Platform A next-generation telemedicine platform providing remote patient monitoring and telehealth capabilities. It enables healthcare providers to conduct audio-visual remote visits with patients while capturing and visualizing heart and lung sounds via a connected device, making remote examinations comparable to in-person clinical visits.
- Steth IO Spot Digital Stethoscope A smartphone-compatible digital stethoscope device that plugs directly into a patient's smartphone to capture heart and lung sounds. The captured audio signals are transmitted to the provider during telemedicine visits and displayed visually on the provider screen for enhanced diagnostic accuracy.
- Telaspot by Steth IO A scalable continuous care platform that combines telemedicine visits, scheduling, messaging between patients and physicians, and remote patient monitoring in one unified system. The platform can be customized and branded for individual clinics and healthcare organizations, with one-click implementation allowing providers to launch their virtual clinic and enroll patients within minutes.
Quantifiable outcome
- Reduced telemedicine implementation time from 16-24 months to one-click deployment
- +4 more outcomes
Companies that use Steth IO
Customer profileSegments4 records
Ideal customer profiles3 records
Steth IO technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability5 records
Feature4 records
Steth IO partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Webex by CiscocoreSteth IO has partnered with Cisco Webex to embed its telemedicine application directly within the Webex collaboration platform. The Steth IO telemedicine system provides next-generation telemedicine capabilities through a hybrid audio-visual examination platform and connected device that captures heart and lung sounds. With these augmented telemedicine capacities, Steth IO empowers telemedicine providers to offer greater accuracy and a smoother exam experience comparable clinically to an in-person visit. Webex believes the future of work is hybrid and is enabling app partners to deliver unique workflows directly within the Webex experience through Embedded Apps.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Steth IO competitors and assessment
Company assessmentDirect peers
- Vivify Health: Vivify Health provides a connected-health RPM platform used by health systems and payers to manage chronic conditions including CHF and COPD. It overlaps with Steth IO's Telaspot continuous-care positioning for chronic-disease monitoring at home.
- AliveCor: AliveCor makes the KardiaMobile personal ECG device and a clinician AI-ECG platform. It is directly comparable to Steth IO in the consumer-and-clinician cardiac diagnostics category, with stronger consumer brand recognition but a narrower (ECG-only) signal set than Steth IO's heart-and-lung auscultation.
- Eko Health: Eko Health manufactures the CORE digital stethoscope and a telehealth/AI platform that analyzes heart and lung sounds. It is the closest direct competitor to Steth IO's Spot device and visual-audio auscultation platform, with far greater capital, FDA clearances, and provider adoption.
- TytoCare: TytoCare offers a handheld remote examination device paired with a telehealth platform for guided home exams of heart, lung, throat, skin, and ears. It is directly comparable to Steth IO's Spot + Telaspot combination, particularly for primary care and chronic-condition RPM use cases.
- iRhythm Technologies: iRhythm makes the Zio wearable cardiac monitoring patch and an AI-based ECG analysis service. It is comparable to Steth IO in the cardiac RPM niche, although it focuses on longer-duration ambulatory ECG monitoring rather than point-of-care auscultation.
Broad incumbents
- Amwell: Amwell is a major enterprise telehealth platform with deep health-system integrations and a connected-device program. It competes with Steth IO's Telaspot platform at the provider-software layer, particularly for organizations that prefer to buy telehealth through a single incumbent vendor.
- Doximity: Doximity's Dialer and telehealth tools are widely adopted by US physicians for simple virtual visits. While Doximity does not offer auscultation hardware, it sets the baseline expectation for physician-facing telemedicine UX that Steth IO's Telaspot must exceed to drive adoption.
- Teladoc Health: Teladoc Health is a large publicly-traded telehealth platform with enterprise health-system contracts across multiple specialties. While not a hardware peer, it competes for the same provider budget and patient visits and limits Steth IO's ability to upsell stand-alone device-led RPM.
- 3M Littmann (Solventum): 3M Littmann is the dominant traditional stethoscope brand and, through Solventum and Eko partnerships, is expanding into digital/connected auscultation. It represents the broad incumbent that providers default to and against which Steth IO must differentiate on digital-native capabilities.
Emerging players
- Heartbeat Health: Heartbeat Health is a virtual cardiology practice and RPM platform for patients with heart failure and arrhythmias. It is comparable to Steth IO as a competitor for cardiology-specific telehealth and remote cardiac monitoring budgets, though it is a services-led model rather than a hardware one.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Steth IO social profiles
Digital presenceSteth IO compliance and trust
Trust signalCompliance1 record
Steth IO financial estimates
Financial estimateRevenue estimate
Valuation estimate
Steth IO leadership team
Management profileNumber of profiles
Profiles1 record
Steth IO funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Steth IO M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Steth IO
What does Steth IO do?
Steth IO develops and sells a smartphone-compatible digital stethoscope device (Spot) paired with a cloud-based telemedicine platform that enables healthcare providers to conduct remote cardiopulmonary examinations during live audio-visual visits. The platform visually represents heart and lung sounds captured by the connected device, allowing physicians to diagnose abnormalities with greater accuracy than traditional telemedicine. The Telaspot continuous care platform extends this with integrated scheduling, messaging, and remote patient monitoring capabilities for healthcare institutions.
Is Steth IO a public or private company?
Steth IO is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Steth IO founded?
Steth IO was founded in 2015. It employs 1 to 10 people.
Where is Steth IO based?
Steth IO is headquartered in Bothell, United States, in the North America region.
How does Steth IO make money?
Three revenue lines are on record. Hardware Device Sales (Spot) is the primary driver. The others are software Platform Subscription and in-App Purchases.
Who are Steth IO's main competitors?
Direct peers on record are Vivify Health, AliveCor, Eko Health, TytoCare and iRhythm Technologies. Broad incumbents are Amwell, Doximity, Teladoc Health and 3M Littmann (Solventum). Heartbeat Health is listed as an emerging player.
Does Steth IO have an API?
No public API is recorded for Steth IO.
What industry is Steth IO in?
Steth IO's product category is Telemedicine and Remote Patient Monitoring. Its primary akta.pro industry code is HLALAGAB, Cardiology Telemedicine Platforms, with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.